Zhejiang Medicine Co.,Ltd.’s Net Profit Rose 15% in First Half of 2021

Zhejiang Medicine Co.,Ltd. (浙江医药股份有限公司) (600216.SH) reported a net profit of 468.9 million yuan in the first half of 2021, up 15% year-on-year.

Meanwhile, the company posted 4.6 billion yuan in revenue, up 30.9% year-on-year.

At the end of the reporting period, it had 12 billion yuan in total assets and 3.3 billion yuan in total liabilities, with a liability-to-asset ratio of 27.7%.

This article was automatically produced by Caixin Automation on Sept. 1, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.